Dreamtech Q1 2026 consolidated operating profit plummets... turns to net loss

Q1 2026 consolidated revenue: KRW 260,706 million (down 23.6% YoY)
Consolidated operating profit: KRW 413 million (plummeting 98.7% from KRW 31,373 million YoY)
Consolidated net loss: KRW 4,364 million (vs net income of KRW 13,247 million YoY)
Standalone operating profit: KRW 3,961 million, net income: KRW 4,011 million
Consolidated EPS: -96 won, standalone EPS: 61 won
Total liabilities: KRW 412,786 million, total equity: KRW 475,515 million (debt ratio 86.8%)
Credit rating maintained at BBB- (NICE)
Decided to pay KRW 226 per share cash dividend for FY2025 (payout ratio 66.32%), dividend payable KRW 14,867 million
Treasury shares: 3,106,033 shares (4.50%), no short-term buyback or cancellation plan
Key loss drivers: FX loss of KRW 8,789 million, equity method loss of KRW 1,167 million
India subsidiary net loss: KRW 8,664 million; Cardiac Insight net loss: KRW 2,734 million
R&D expenses: KRW 3,498 million (3.08% of revenue)